Trisapatide

product on 1 show · 2 statements across 1 episodes

BigDeal

2 statements about Trisapatide, every show

BIGDEAL Assertion Partly supported
Israetel: Tirzepatide outperforms Ozempic, with more potent fifth-gen GLP drugs in trials
“Technically it's a third generation GLP drug, but fourth gen is Trisapatide. It's already on the market, Manjaro. Fewer side effects, bigger primary effect. There are fifth gen drugs currently in FDA approval process, which make Ozempic look like a starter pac…”
Dr. Mike Israetel Nov 13, 2024 ▶ 11:40 THIS One Thing All Fit People Know — | Mike Israetel
BIGDEAL Assertion Supported
Israetel: GLP-1 drugs curb obesity primarily by lowering genetic food drive
“New medications like Ozempic, Trisapatide, et cetera, Manjaro, all those things. While, why they were some of the only things to really take a big chunk out of obesity is because they take your, whatever genetic food drive and palatability drive you have, how …”
Dr. Mike Israetel Nov 13, 2024 ▶ 10:15 THIS One Thing All Fit People Know — | Mike Israetel

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.